基于CRISPR-Cas9的基因敲除扩展NK细胞中的免疫检查点
Tahereh Mohammadian Gol1, Miso Kim1, Ralph Sinn1
1Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, 72076 Tübingen, Germany.
International journal of molecular sciences
|November 25, 2023
概括
在自然杀手 (NK) 细胞中抑制免疫检查点的CRISPR-Cas9基因编辑并没有显著提高其杀死癌症的能力. 需要进一步的研究来增强NK细胞免疫疗法用于白血病治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 基因治疗 基因治疗
背景情况:
- 自然杀手 (NK) 细胞免疫疗法在白血病治疗方面显示出有前途.
- 调节NK细胞中的抑制信号通路对于增强抗白血病活性至关重要.
- 优化基于NK细胞的免疫疗法需要进一步研究如何增强其细胞毒性功能.
研究的目的:
- 研究是否抑制特定的抑制受体 (A2AR,CBLB,NKG2A,CD96) 可以增强扩张和激活NK细胞的抗白血病活性.
- 评估CRISPR-Cas9基因编辑对NK细胞中这些抑制标的有效性.
- 评估这些淘汰赛对NK细胞细胞毒性对白血病细胞的影响.
主要方法:
- 利用CRISPR-Cas9基因编辑,在扩展的人类NK细胞中淘汰A2AR,CBLB,NKG2A和CD96.
- 通过英德尔频率分析,流细胞计和西布洛特确认了淘汰效率.
- 评估了基因编辑NK细胞对急性髓性白血病 (AML) 和B细胞急性淋巴细胞白血病 (B-ALL) 细胞系的体外细胞毒性.
主要成果:
- 在扩展的NK细胞中,CRISPR-Cas9介导的A2AR,CBLB,NKG2A和CD96的淘汰成功地实现了良好的效率.
- 淘汰NKG2A和CBLB只导致NK细胞对白血病细胞的细胞毒性仅略有改善.
- 抑制A2AR和淘汰CD96并没有显著增强NK细胞的抗白血病活性.
结论:
- 单独对特定免疫检查点的CRISPR-Cas9中介淘汰可能不足以显著增强扩大NK细胞的抗白血病功能.
- 强大的细胞激活信号,可能通过诸如化学抗原受体 (CAR) 表达等方法,是优化NK细胞基础免疫疗法的必要条件.
- 需要进一步的策略来提高NK细胞免疫疗法治疗白血病的疗效.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


